Grown Rogue International (GRUSF) Change in Acquisitions & Divestments (2018 - 2020)
Grown Rogue International's (GRUSF) quarterly Change in Acquisitions & Divestments came in at -$283646.0 in Q2 2020, down 35.68% year-on-year from -$441023.6 in Q2 2019, and down 312.24% quarter-over-quarter from $133646.0 in Q1 2020.
Grown Rogue International (GRUSF) Change in Acquisitions & Divestments (2018 - 2020) Analysis & Trends
Grown Rogue International's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at -$283646.0 for Q2 2020.
- On a quarterly basis, Change in Acquisitions & Divestments fell 35.68% year-over-year to -$283646.0 in Q2 2020; TTM through Apr 2020 was -$397934.0, a 160.99% decrease from a year earlier, with the FY2021 full-year figure at -$750000.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments retreated to -$283646.0 in Q2 2020 per GRUSF's latest filing, from $133646.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $1.4 million in Q1 2018 and bottomed at -$865466.0 in Q2 2018.
- The 3-year median for Change in Acquisitions & Divestments is -$123967.0 (2019), against an average of $75156.9.
- Biggest YoY gain for Change in Acquisitions & Divestments was 83.37% in 2019; the steepest drop was 125.07% in 2019.
- Year by year, Change in Acquisitions & Divestments stood at $725958.0 in 2018, then sank by 125.07% to -$182029.0 in 2019, then tumbled by 55.82% to -$283646.0 in 2020.
- Per Business Quant, the three latest GRUSF Change in Acquisitions & Divestments figures stand at -$283646.0 (Q2 2020), $133646.0 (Q1 2020), and -$182029.0 (Q4 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2020 | -283,646.00 |
| Apr 30, 2020 | -283,646.00 |
| Jan 31, 2020 | 133,646.00 |
| Jan 31, 2020 | 133,646.00 |
| Oct 31, 2019 | -182,029.00 |
| Oct 31, 2019 | -182,029.00 |
| Jul 31, 2019 | -65,905.00 |
| Jul 31, 2019 | -65,905.00 |
| Apr 30, 2019 | -209,048.00 |
| Apr 30, 2019 | -209,048.00 |
| Jan 31, 2019 | 531,908.00 |
| Jan 31, 2019 | 531,908.00 |
| Oct 31, 2018 | 725,958.00 |
| Oct 31, 2018 | 725,958.00 |
| Jul 31, 2018 | -396,374.00 |
| Jul 31, 2018 | -396,374.00 |
| Apr 30, 2018 | -865,466.00 |
| Apr 30, 2018 | -865,466.00 |
| Jan 31, 2018 | 1.36 Mn |
| Jan 31, 2018 | 1.36 Mn |